Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Randall Kaye Insider Profile
4 Followers
Randall Kaye, Sr. VP, Chief Medical Officer at Avanir Pharmaceuticals, holds 0.00 shares in Longboard Pharmaceuticals (Ticker: LBPH), holds 78.19K shares in Avanir Pharmaceuticals (Ticker: AVNR).
Randall Kaye Avanir Pharmaceuticals (AVNR)Sr. VP, Chief Medical Officer
Avanir Pharmaceuticals (AVNR)
Sr. VP, Chief Medical Officer
Not Ranked
Randall Kaye has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Randall Kaye does not currently own shares as a corporate insider.
A breakdown of Randall Kaye's holdings
Insider Roles
Randall Kaye does not currently hold a role as a corporate insider.
Roles that Randall Kaye holds in companies
Most Profitable Insider Trade
Stock:
Longboard Pharmaceuticals
(LBPH)
(LBPH)
Rating:Informative Buy
Date:Aug 13, 2024 - Today
Return:+71.90%
The most profitable trade made by Randall Kaye
Randall Kaye's Trading History
Avanir Pharmaceuticals
Sep 13, 2011
―
Uninformative Sell
275.00K
―
Longboard Pharmaceuticals
Dec 02, 2024
―
Uninformative Sell
1.83M
$0.00
List of latest transactions for each holding click on a transaction to see Randall Kaye's performance on stock
You May Also Like
Randall Kaye insider profile FAQ
What is the percentage of profitable transactions made by Randall Kaye?
The percentage of profitable transactions made by Randall Kaye is ―.
What is the average return per transaction made by Randall Kaye?
The average return per transaction made by Randall Kaye is ―.
What stocks does Randall Kaye hold?
Randall Kaye holds: AVNR, LBPH stocks.
What was Randall Kaye’s latest transaction?
Randall Kaye latest transaction was an Uninformative Sell of $1.83M.
What was Randall Kaye's most profitable transaction?
Randall Kaye’s most profitable transaction was an Informative Buy of LBPH stock on August 13, 2024. The return on the trade was 71.90%.
What is Randall Kaye's role in Avanir Pharmaceuticals?
Randall Kaye's role in Avanir Pharmaceuticals is Sr. VP, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.